Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report)’s share price fell 1.6% on Wednesday . The stock traded as low as $1.21 and last traded at $1.25. 263,962 shares traded hands during trading, an increase of 293% from the average session volume of 67,097 shares. The stock had previously closed at $1.27.
Cardiol Therapeutics Stock Down 1.6 %
The business has a fifty day moving average price of $1.48 and a two-hundred day moving average price of $1.83.
Cardiol Therapeutics Company Profile
Cardiol Therapeutics Inc is a clinical-stage biotechnology company that focuses on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its product, CardiolRx, is a pharmaceutically produced extra strength oral cannabidiol formulation that is entering a Phase II/III outcomes study in hospitalized patients testing positive for the COVID-19 virus.
Further Reading
- Five stocks we like better than Cardiol Therapeutics
- How to Calculate Stock Profit
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- What to Know About Investing in Penny Stocks
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
